Arbutus Biopharma Corp (ABUS)
3.955
+0.10
(+2.46%)
USD |
NASDAQ |
Nov 05, 16:00
3.955
0.00 (0.00%)
After-Hours: 16:04
Arbutus Biopharma Total Liabilities (Quarterly): 37.59M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 37.59M |
| March 31, 2024 | 35.65M |
| December 31, 2023 | 38.38M |
| September 30, 2023 | 39.30M |
| June 30, 2023 | 42.13M |
| March 31, 2023 | 47.31M |
| December 31, 2022 | 58.57M |
| September 30, 2022 | 58.28M |
| June 30, 2022 | 62.69M |
| March 31, 2022 | 71.03M |
| December 31, 2021 | 35.05M |
| September 30, 2021 | 35.46M |
| June 30, 2021 | 34.55M |
| March 31, 2021 | 32.09M |
| December 31, 2020 | 35.11M |
| September 30, 2020 | 33.76M |
| June 30, 2020 | 32.11M |
| March 31, 2020 | 29.36M |
| December 31, 2019 | 32.79M |
| September 30, 2019 | 33.64M |
| June 30, 2019 | 28.10M |
| March 31, 2019 | 28.01M |
| December 31, 2018 | 27.67M |
| September 30, 2018 | 30.15M |
| June 30, 2018 | 38.94M |
| Date | Value |
|---|---|
| March 31, 2018 | 37.61M |
| December 31, 2017 | 54.69M |
| September 30, 2017 | 72.45M |
| June 30, 2017 | 79.29M |
| March 31, 2017 | 79.04M |
| December 31, 2016 | 72.91M |
| September 30, 2016 | 98.10M |
| June 30, 2016 | 99.54M |
| March 31, 2016 | 165.18M |
| December 31, 2015 | 164.61M |
| September 30, 2015 | 168.82M |
| June 30, 2015 | 185.32M |
| March 31, 2015 | 193.37M |
| December 31, 2014 | 30.14M |
| September 30, 2014 | 29.56M |
| June 30, 2014 | 26.92M |
| March 31, 2014 | 33.04M |
| December 31, 2013 | 12.52M |
| September 30, 2013 | 13.54M |
| June 30, 2013 | 11.89M |
| March 31, 2013 | 12.63M |
| December 31, 2012 | 11.68M |
| September 30, 2012 | 9.978M |
| June 30, 2012 | 8.092M |
| March 31, 2012 | 9.309M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
29.36M
Minimum
Mar 2020
71.03M
Maximum
Mar 2022
41.64M
Average
35.65M
Median
Mar 2024
Total Liabilities (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 1.438B |
| GlycoMimetics Inc | 4.356M |
| FibroGen Inc | 483.58M |
| Cidara Therapeutics Inc | 42.42M |
| Cue Biopharma Inc | 20.71M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 160.04M |
| Shareholders Equity (Quarterly) | 122.45M |
| Current Ratio | 6.560 |